Hu, M.* ; Cebola, I.* ; Carrat, G.* ; Jiang, S.* ; Nawaz, S.* ; Khamis, A.* ; Canouil, M.* ; Froguel, P.* ; Schulte, A.* ; Solimena, M. ; Ibberson, M.* ; Marchetti, P.* ; Cardenas-Diaz, F.L.* ; Gadue, P.J.* ; Hastoy, B.* ; Alemeida-Souza, L.* ; McMahon, H.* ; Rutter, G.A.*
Chromatin 3D interaction analysis of the STARD10 locus unveils FCHSD2 as a regulator of insulin secretion.
Cell Rep. 34:108703 (2021)
Using chromatin conformation capture, we show that an enhancer cluster in the STARD10 type 2 diabetes (T2D) locus forms a defined 3-dimensional (3D) chromatin domain. A 4.1-kb region within this locus, carrying 5 T2D-associated variants, physically interacts with CTCF-binding regions and with an enhancer possessing strong transcriptional activity. Analysis of human islet 3D chromatin interaction maps identifies the FCHSD2 gene as an additional target of the enhancer cluster. CRISPR-Cas9-mediated deletion of the variant region, or of the associated enhancer, from human pancreas-derived EndoC-βH1 cells impairs glucose-stimulated insulin secretion. Expression of both STARD10 and FCHSD2 is reduced in cells harboring CRISPR deletions, and lower expression of STARD10 and FCHSD2 is associated, the latter nominally, with the possession of risk variant alleles in human islets. Finally, CRISPR-Cas9-mediated loss of STARD10 or FCHSD2, but not ARAP1, impairs regulated insulin secretion. Thus, multiple genes at the STARD10 locus influence β cell function.
Altmetric
Additional Metrics?
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Corresponding Author
Keywords
Fchsd2 ; Gwas ; Stard10 ; T2d ; Chromatin Structure ; Enhancer Cluster ; Gene Regulation ; Genetic Variant ; Insulin Secretion ; Type 2 Diabetes; Genome-wide Association; Genetic Architecture; Provides Insights; Enhancer; Ctcf; Transcription; Expression; Pathophysiology; Defines; Islets
Keywords plus
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 34,
Issue: 5,
Pages: ,
Article Number: 108703
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
Grants
EFPIA
MRC
Experimental Challenge Grant (DIVA)
Medical Research Council (MRC) Programme grants
Diabetes UK
European Union
European Union's Horizon 2020 research and innovation programme via the Innovative Medicines Initiative 2 Joint Undertaking
Imperial Biomedical Research Centre
National Institute for Health Research (NIHR)
Government Department for Business, Energy, and Industrial Strategy
Global Challenges Research Fund
British Heart Foundation
Royal Society Wolfson Research Merit Award
Imperial Confidence in Concept (ICiC) grants
Wellcome Trust